Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

2019 - Webinar Series on Liver (2018-2019)


This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA

Autoimmune Liver Disease 360º

3.1 - Autoimmune Liver Disease 360º

Presenter: David Assis, Julie Heimbach, New Haven, CT, USA
Authors: David Assis, Julie Heimbach, Sukru Emre

Overview:

Treatment of autoimmune liver diseases have many challenges both pre and post transplantation including decision making for transplantation, specific transplant evaluation process, transplant surgery and postoperative care. In this webinar, these problems will be discussed by 2 expert in this field.

 


Learning Objectives:

  1. to manage patients with autoimmune liver disease pretransplant
  2. to evaluate patients with autoimmune liver diseases for transplantation
  3. to recognize the specific transplant related problems in this patient population
  4. to predict possible post-operative complications specific to autoimmune liver disease
  5. the specific protocols transplanting patient with cholangiocarcinama

 


David Assis Biography:

Dr. David N. Assis is a hepatologist and assistant professor of medicine at Yale University School of Medicine. His training in liver diseases, including research fellowship and transplant hepatology, took place at Yale. He now focuses on autoimmune liver diseases in his clinical practice and also performs NIH-funded translational research to better understand the mechanisms of Autoimmune Hepatitis, Primary Biliary Cholangitis and Primary Sclerosing Cholangitis, and to develop new immune-based therapies for treatment of these disorders.

Julie K. Heimbach Biography:

Julie K. Heimbach, M.D., is a Professor of Surgery and the Chair of the Division of Transplantation Surgery at Mayo Clinic in Rochester, Minnesota. She is currently a member of the Governing Board of the American Association for the Study of Liver Disease; chair of the Communications Committee of the American Society of Transplant Surgeons; and chair of the Liver and Intestinal Transplant Committee of the OPTN/UNOS, the national organization charged with oversight of organ transplantation in the United States. She also serves as associate editor of the American Journal of Transplantation. Dr. Heimbach’s research focuses on living donor transplantation, obesity and transplantation, and liver transplantation for hilar cholangiocarcinoma.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada